ArticlePloS one2020

A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer.

Yuji Miyamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.